Suppr超能文献

长链非编码RNA XIST通过miR-155/CDX1轴抑制乳腺癌细胞的生长、迁移和侵袭。

Long non-coding RNA XIST inhibited breast cancer cell growth, migration, and invasion via miR-155/CDX1 axis.

作者信息

Zheng Ruinian, Lin Shunhuan, Guan Ling, Yuan Huiling, Liu Kejun, Liu Chun, Ye Weibiao, Liao Yuting, Jia Jun, Zhang Ruopeng

机构信息

Department of Oncology, Dongguan People's Hospital, Southern Medical University, Dongguan, China.

Clinical Research Center, Dongguan People's Hospital, Southern Medical University, Dongguan, China.

出版信息

Biochem Biophys Res Commun. 2018 Apr 15;498(4):1002-1008. doi: 10.1016/j.bbrc.2018.03.104. Epub 2018 Mar 19.

Abstract

Long non-coding RNA (lncRNA) is an important member of non-coding RNA family and emerging evidence has indicated that it plays a pivotal role in many physiological and pathological processes. The lncRNA X inactive specific transcript (XIST) is a potential tumour suppressor in some types of cancers. However, the expression and function of XIST in breast cancer remain largely unclear. The objective of this study was to evaluate the expression and biological role of XIST in breast cancer. The results showed that XIST was significantly down-regulated in breast cancer tissues and cell lines. Further functional analysis indicated that overexpression of XIST remarkably inhibited breast cancer cell growth, migration, and invasion. The results of luciferase reporter assays verified that miR-155 was a direct target of XIST in breast cancer. Moreover, caudal-type homeobox 1 (CDX1) was identified as a direct target of miR-155 and miR-155/CDX1 rescued the effects of XIST in breast cancer cells. Taken together, our results suggest that XIST is down-regulated in breast cancer and suppresses breast cancer cell growth, migration, and invasion via the miR-155/CDX1 axis.

摘要

长链非编码RNA(lncRNA)是非编码RNA家族的重要成员,越来越多的证据表明它在许多生理和病理过程中起关键作用。lncRNA X染色体失活特异性转录本(XIST)在某些类型的癌症中是一种潜在的肿瘤抑制因子。然而,XIST在乳腺癌中的表达和功能仍不清楚。本研究的目的是评估XIST在乳腺癌中的表达及生物学作用。结果显示,XIST在乳腺癌组织和细胞系中显著下调。进一步的功能分析表明,XIST的过表达显著抑制乳腺癌细胞的生长、迁移和侵袭。荧光素酶报告基因检测结果证实,miR-155是乳腺癌中XIST的直接靶点。此外,尾型同源盒1(CDX1)被鉴定为miR-155的直接靶点,miR-155/CDX1可挽救XIST对乳腺癌细胞的影响。综上所述,我们的结果表明,XIST在乳腺癌中表达下调,并通过miR-155/CDX1轴抑制乳腺癌细胞的生长、迁移和侵袭。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验